This Addus HomeCare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Author: Avi Kapoor | December 16, 2024 08:17am
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Goldman Sachs analyst Eric Sheridan initiated coverage on Grindr Inc. (NYSE:GRND) with a Buy rating and announced a price target of $20. Grindr shares closed at $15.74 on Friday. See how other analysts view this stock.
JMP Securities analyst Constantine Davides initiated coverage on Addus HomeCare Corporation (NASDAQ:ADUS) with a Market Outperform rating and announced a price target of $150. Addus HomeCare shares closed at $125.00 on Friday. See how other analysts view this stock.
HC Wainwright & Co. analyst Matthew Caufield initiated coverage on Zenas BioPharma, Inc. (NASDAQ:ZBIO) with a Buy rating and announced a price target of $30. Zenas BioPharma shares closed at $8.92 on Friday. See how other analysts view this stock.
JMP Securities analyst Constantine Davides initiated coverage on U.S. Physical Therapy, Inc. (NYSE:USPH) with a Market Outperform rating and announced a price target of $113. US Physical Therapy shares closed at $93.46 on Friday. See how other analysts view this stock.
Jones Trading analyst Justin Walsh initiated coverage on Alto Neuroscience, Inc. (NYSE:ANRO) with a Buy rating and announced a price target of $18. Alto Neuroscience shares closed at $3.83 on Friday. See how other analysts view this stock.
Considering buying ADUS stock? Here’s what analysts think:
Read This Next: Wall Street’s Most Accurate Analysts Give Their Take On 3 Energy Stocks With Over 6% Dividend Yields
